Cite
Anti‐HER2 Immunoliposomes: Antitumor Efficacy Attributable to Targeted Delivery of Anthraquinone‐Fused Enediyne.
MLA
Feng, Xueqiong, et al. “Anti‐HER2 Immunoliposomes: Antitumor Efficacy Attributable to Targeted Delivery of Anthraquinone‐Fused Enediyne.” Advanced Science, vol. 11, no. 17, May 2024, pp. 1–12. EBSCOhost, https://doi.org/10.1002/advs.202307865.
APA
Feng, X., Wen, Z., Zhu, X., Yan, X., Duan, Y., & Huang, Y. (2024). Anti‐HER2 Immunoliposomes: Antitumor Efficacy Attributable to Targeted Delivery of Anthraquinone‐Fused Enediyne. Advanced Science, 11(17), 1–12. https://doi.org/10.1002/advs.202307865
Chicago
Feng, Xueqiong, Zhongqing Wen, Xiangcheng Zhu, Xiaohui Yan, Yanwen Duan, and Yong Huang. 2024. “Anti‐HER2 Immunoliposomes: Antitumor Efficacy Attributable to Targeted Delivery of Anthraquinone‐Fused Enediyne.” Advanced Science 11 (17): 1–12. doi:10.1002/advs.202307865.